First Eagle Investment Management’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.93M Buy
440,207
+117,500
+36% +$790K ﹤0.01% 324
2026
Q1
$2.09M Buy
322,707
+10,000
+3% +$69.1K ﹤0.01% 319
2025
Q4
$2.46M Buy
312,707
+21,316
+7% +$137K ﹤0.01% 310
2025
Q3
$1.45M Buy
291,391
+169,352
+139% +$865K ﹤0.01% 322
2025
Q2
$720K Buy
+122,039
New +$645K ﹤0.01% 358

Other funds holding PROF

First Eagle Investment Management's PROF Position: Q2 2026 in Review

First Eagle Investment Management increased its Profound Medical (PROF) stake by 36% in Q2 2026, buying an estimated $790K and bringing the position to 440,207 shares worth $2.93M. The position accounts for ﹤0.01% of the portfolio, ranked #324.

First Eagle Investment Management first reported a position in PROF in Q2 2025 and has held it in 5 quarters since. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • First Eagle Investment Management held 440,207 shares of Profound Medical worth $2.93M as of Q2 2026.
  • First Eagle Investment Management bought 117,500 Profound Medical shares in Q2 2026, an estimated $790K.
  • Profound Medical made up ﹤0.01% of First Eagle Investment Management's portfolio in Q2 2026, its #324 holding.
  • First Eagle Investment Management first reported a position in Profound Medical in Q2 2025 and has held it in 5 quarters since.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on First Eagle Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.